Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer
Clinical trial NCT01790516 · TERMINATED
Trial details
- NCT number
- NCT01790516
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.